Global disparities in availability of epinephrine auto-injectors.
Adrenaline
Adrenaline auto-injector
Anaphylaxis
Epinephrine auto-injector
Management
Survey
Treatment
World allergy organization (WAO)
Journal
The World Allergy Organization journal
ISSN: 1939-4551
Titre abrégé: World Allergy Organ J
Pays: United States
ID NLM: 101481283
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
06
06
2023
revised:
05
09
2023
accepted:
11
09
2023
medline:
2
11
2023
pubmed:
2
11
2023
entrez:
2
11
2023
Statut:
epublish
Résumé
Anaphylaxis is the most severe clinical presentation of acute systemic allergic reactions and can cause death. Given the prevalence of anaphylaxis within healthcare systems, it is a high priority public health issue. However, management of anaphylaxis - both acute and preventative - varies by region. The World Allergy Organization (WAO) Anaphylaxis Committee and the WAO Junior Members Steering Group undertook a global online survey to evaluate local practice in the diagnosis and management of anaphylaxis across regions. Responses were received from WAO members in 66 countries. While intramuscular epinephrine (adrenaline) is first-line treatment for anaphylaxis, some countries continue to recommend alternative routes in contrast to guidelines. Epinephrine auto-injector (EAI) devices, prescribed to individuals at ongoing risk of anaphylaxis in the community setting, are This survey provides a global snapshot view of the current management of anaphylaxis, and highlights key unmet needs including the global availability of epinephrine for self-injection as a key component of anaphylaxis management.
Sections du résumé
Background
UNASSIGNED
Anaphylaxis is the most severe clinical presentation of acute systemic allergic reactions and can cause death. Given the prevalence of anaphylaxis within healthcare systems, it is a high priority public health issue. However, management of anaphylaxis - both acute and preventative - varies by region.
Methods
UNASSIGNED
The World Allergy Organization (WAO) Anaphylaxis Committee and the WAO Junior Members Steering Group undertook a global online survey to evaluate local practice in the diagnosis and management of anaphylaxis across regions.
Results
UNASSIGNED
Responses were received from WAO members in 66 countries. While intramuscular epinephrine (adrenaline) is first-line treatment for anaphylaxis, some countries continue to recommend alternative routes in contrast to guidelines. Epinephrine auto-injector (EAI) devices, prescribed to individuals at ongoing risk of anaphylaxis in the community setting, are
Conclusion
UNASSIGNED
This survey provides a global snapshot view of the current management of anaphylaxis, and highlights key unmet needs including the global availability of epinephrine for self-injection as a key component of anaphylaxis management.
Identifiants
pubmed: 37915955
doi: 10.1016/j.waojou.2023.100821
pii: S1939-4551(23)00081-9
pmc: PMC10616381
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100821Informations de copyright
© 2023 The Author(s).
Déclaration de conflit d'intérêts
The authors declare that they do not have any conflict of interests related to the contents of this article.
Références
Ann Allergy Asthma Immunol. 2010 May;104(5):405-12
pubmed: 20486330
Allergy. 2014 Aug;69(8):1026-45
pubmed: 24909803
J Allergy Clin Immunol. 2019 Sep;144(3):627-633
pubmed: 31229269
Allergy. 2022 Sep;77(9):2618-2633
pubmed: 35266160
Rev Alerg Mex. 2019;66 Suppl 2:1-39
pubmed: 31443138
World Allergy Organ J. 2023 Jul 12;16(7):100798
pubmed: 37501656
Allergy Asthma Immunol Res. 2016 Jul;8(4):383-8
pubmed: 27126732
World Allergy Organ J. 2019 Oct 31;12(10):100066
pubmed: 31719946
J Investig Allergol Clin Immunol. 2020 Apr;30(2):77-85
pubmed: 32327400
Clin Exp Allergy. 2023 Sep;53(9):955-958
pubmed: 37464961
CJEM. 2021 Jul;23(4):480-493
pubmed: 33844191
Ann Allergy Asthma Immunol. 2005 May;94(5):534-8
pubmed: 15945555
Ann Allergy Asthma Immunol. 2009 May;102(5):403-9
pubmed: 19492662
Allergy. 2017 Jan;72(1):120-125
pubmed: 27537103
Allergy. 2012 Jun;67(6):783-9
pubmed: 22519410
World Allergy Organ J. 2019 Dec 02;12(11):100089
pubmed: 31871534
Clin Transl Allergy. 2014 Nov 28;4:42
pubmed: 25905010
Allergy Asthma Clin Immunol. 2018 Apr 4;14:12
pubmed: 29632547
Int Arch Allergy Immunol. 2017;173(3):171-177
pubmed: 28793302
JAMA Netw Open. 2019 Oct 2;2(10):e1913951
pubmed: 31642933
Curr Opin Allergy Clin Immunol. 2019 Aug;19(4):393-401
pubmed: 31058676
World Allergy Organ J. 2020 Oct 30;13(10):100472
pubmed: 33204386